Knockout Tested Rabbit Recombinant Monoclonal NF2 / Merlin antibody. Carrier free. Suitable for WB and reacts with Human, Mouse samples.
pH: 7.2 - 7.4
Constituents: PBS
WB | |
---|---|
Human | Tested |
Mouse | Tested |
Rat | Predicted |
Species | Dilution info | Notes |
---|---|---|
Species Human, Mouse | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Rat | Dilution info - | Notes - |
Probable regulator of the Hippo/SWH (Sav/Wts/Hpo) signaling pathway, a signaling pathway that plays a pivotal role in tumor suppression by restricting proliferation and promoting apoptosis. Along with WWC1 can synergistically induce the phosphorylation of LATS1 and LATS2 and can probably function in the regulation of the Hippo/SWH (Sav/Wts/Hpo) signaling pathway. May act as a membrane stabilizing protein. May inhibit PI3 kinase by binding to AGAP2 and impairing its stimulating activity. Suppresses cell proliferation and tumorigenesis by inhibiting the CUL4A-RBX1-DDB1-VprBP/DCAF1 E3 ubiquitin-protein ligase complex.
SCH, NF2, Merlin, Moesin-ezrin-radixin-like protein, Neurofibromin-2, Schwannomerlin, Schwannomin
Knockout Tested Rabbit Recombinant Monoclonal NF2 / Merlin antibody. Carrier free. Suitable for WB and reacts with Human, Mouse samples.
pH: 7.2 - 7.4
Constituents: PBS
ab247805 is the carrier-free version of Anti-NF2 / Merlin antibody [EPR2573(2)] ab109244.
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
This product is a recombinant monoclonal antibody, which offers several advantages including:
For more information, read more on recombinant antibodies.
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. The carrier-free buffer and high concentration allow for increased conjugation efficiency.
This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
The NF2 gene produces a protein known as Neurofibromin 2 often called Merlin. The NF2 protein or Merlin protein plays a mechanical role in the cell as a tumor suppressor by stabilizing cellular structure and regulating cell growth. Its molar mass is approximately 70 kDa. NF2 protein is found mainly in the nervous system particularly in Schwann cells which are important for nerve function.
The NF2 protein functions to control cell proliferation differentiation and motility. It associates with the cytoskeleton acting as a bridge between cell surface proteins and the actin cytoskeleton. Merlin as part of the ERM (ezrin radixin moesin) family contributes to the assembly of protein complexes at the cell membrane. Through its interactions it plays a significant role in maintaining proper cell signaling and structural integrity.
NF2 protein integrates into the Hippo signaling pathway which regulates organ size by controlling cell growth and apoptosis. Within this pathway Merlin interacts with members such as YAP1 and LATS1/2 moderating their activity to prevent over-proliferation of cells. NF2 also connects with the mTOR pathway which is critical for cell metabolism and growth further emphasizing its regulatory functions in cellular homeostasis.
Mutations or deletions in the NF2 gene are associated with neurofibromatosis type 2 a condition that causes benign tumors on nerve tissues known as schwannomas. NF2 protein is linked to other proteins such as angiogenesis factors contributing to the development of these tumors. Schwannomatosis another disorder related to NF2 involves nerve sheath tumor formation with Merlin mutation playing a role indicating its importance in nervous system health.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
This data was developed using the same antibody clone in a different buffer formulation (Anti-NF2 / Merlin antibody [EPR2573(2)] ab109244).
Lanes 1 - 2: Merged signal (red and green). Green - Anti-NF2 / Merlin antibody [EPR2573(2)] ab109244 observed at 60 kDa. Red - loading control Anti-GAPDH antibody [6C5] - Loading Control ab8245 (Mouse anti-GAPDH antibody [6C5]) observed at 37kDa.
Anti-NF2 / Merlin antibody [EPR2573(2)] ab109244 was shown to react with NF2 in wild-type HeLa cells in western blot with loss of signal observed in NF2 knockout cell line Human NF2 (Merlin) knockout HeLa cell line ab261796 (NF2 knockout cell lysate Human NF2 (Merlin) knockout HeLa cell lysate ab257179). Wild-type and NF2 knockout HeLa cell lysates were subjected to SDS-PAGE. Membranes were blocked in 3% milk in TBS-T (0.1% Tween®) before incubation with Anti-NF2 / Merlin antibody [EPR2573(2)] ab109244 and Anti-GAPDH antibody [6C5] - Loading Control ab8245 (Mouse anti-GAPDH antibody [6C5]) overnight at 4°C at a 1 in 1000 dilution and a 1 in 20000 dilution respectively. Blots were incubated with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes: Western blot - Anti-NF2 / Merlin antibody [EPR2573(2)] (Anti-NF2 / Merlin antibody [EPR2573(2)] ab109244) at 1/1000 dilution
Lane 1: Wild-type HeLa cell lysate at 20 µg
Lane 2: NF2 knockout HeLa cell lysate at 20 µg
Lane 2: Western blot - Human NF2 (Merlin) knockout HeLa cell line (Human NF2 (Merlin) knockout HeLa cell line ab261796)
Performed under reducing conditions.
Predicted band size: 70 kDa
Observed band size: 60 kDa
False colour image of Western blot: Anti-NF2 / Merlin antibody [EPR2573(2)] staining at 1/50000 dilution, shown in green; Mouse anti-GAPDH antibody [6C5] (Anti-GAPDH antibody [6C5] - Loading Control ab8245) loading control staining at 1/20000 dilution, shown in red. In Western blot, Anti-NF2 / Merlin antibody [EPR2573(2)] ab109244 was shown to bind specifically to NF2 / Merlin. A band was observed at 74 kDa in wild-type HepG2 cell lysates with no signal observed at this size in NF2 knockout cell line Human NF2 (Merlin) knockout Hep G2 cell line ab277859 (knockout cell lysate ab283826). To generate this image, wild-type and NF2 knockout HepG2 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed ab216776) at 1/20000 dilution.
All lanes: Western blot - Anti-NF2 / Merlin antibody [EPR2573(2)] (Anti-NF2 / Merlin antibody [EPR2573(2)] ab109244) at 1/50000 dilution
Lane 1: Wild-type HepG2 cell lysate at 20 µg
Lane 2: NF2 knockout HepG2 cell lysate at 20 µg
Lane 2: Western blot - Human NF2 (Merlin) knockout Hep G2 cell line (Human NF2 (Merlin) knockout Hep G2 cell line ab277859)
Performed under reducing conditions.
Predicted band size: 70 kDa
Observed band size: 74 kDa
This data was developed using Anti-NF2 / Merlin antibody [EPR2573(2)] ab109244, the same antibody clone in a different buffer formulation.
Lane 1: Wild type HAP1 whole cell lysate (20 μg)
Lane 2: NF2 knockout HAP1 whole cell lysate (20 μg)
Lanes 1 - 2: Merged signal (red and green). Green - Anti-NF2 / Merlin antibody [EPR2573(2)] ab109244 observed at 70 kDa. Red - loading control, ab18058, observed at 130 kDa.
Anti-NF2 / Merlin antibody [EPR2573(2)] ab109244 was shown to specifically react with NF2 in wild type cells as signal was lost in NF2 knockout cells. Wild-type and NF2 knockout samples were subjected to SDS-PAGE. Anti-NF2 / Merlin antibody [EPR2573(2)] ab109244 and ab18058 (Mouse anti Vinculin loading control) were incubated overnight at 4°C at 50000 dilution and 1/20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed ab216773 and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed ab216776 secondary antibodies at 1/20000 dilution for 1 hour at room temperature before imaging.
All lanes: Western blot - Anti-NF2 / Merlin antibody [EPR2573(2)] (Anti-NF2 / Merlin antibody [EPR2573(2)] ab109244)
Predicted band size: 70 kDa
This data was developed using Anti-NF2 / Merlin antibody [EPR2573(2)] ab109244, the same antibody clone in a different buffer formulation.
All lanes: Western blot - Anti-NF2 / Merlin antibody [EPR2573(2)] (Anti-NF2 / Merlin antibody [EPR2573(2)] ab109244) at 1/50000 dilution
Lane 1: HeLa cell lysate at 10 µg
Lane 2: MCF7 cell lysate at 10 µg
Lane 3: Jurkat cell lysate at 10 µg
Lane 4: PC3 cell lysate at 10 µg
Predicted band size: 70 kDa
False colour image of Western blot: Anti-NF2 / Merlin antibody [EPR2573(2)] staining at 1/50000 dilution, shown in green; Mouse anti-GAPDH antibody [6C5] (Anti-GAPDH antibody [6C5] - Loading Control ab8245) loading control staining at 1/20000 dilution, shown in red. In Western blot, Anti-NF2 / Merlin antibody [EPR2573(2)] ab109244 was shown to bind specifically to NF2 / Merlin. A band was observed at 73 kDa in wild-type A549 cell lysates with no signal observed at this size in NF2 knockout cell line. To generate this image, wild-type and NF2 knockout A549 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution.
This data was developed using the same antibody clone in a different buffer formulation (Anti-NF2 / Merlin antibody [EPR2573(2)] ab109244).
All lanes: Western blot - Anti-NF2 / Merlin antibody [EPR2573(2)] (Anti-NF2 / Merlin antibody [EPR2573(2)] ab109244) at 1/50000 dilution
Lane 1: Wild-type A549 cell lysate at 20 µg
Lane 2: NF2 knockout A549 cell lysate at 20 µg
Lane 3: SH-SY5Y cell lysate at 20 µg
Performed under reducing conditions.
Predicted band size: 70 kDa
Observed band size: 73 kDa
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com